Leo Wealth LLC lifted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 87.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,690 shares of the company's stock after buying an additional 6,860 shares during the quarter. Leo Wealth LLC's holdings in Procter & Gamble were worth $2,340,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Kingstone Capital Partners Texas LLC increased its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Northern Trust Corp increased its position in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. increased its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after acquiring an additional 1,018,865 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on PG shares. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday. UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday. Barclays lowered their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Finally, BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $172.58.
View Our Latest Analysis on PG
Procter & Gamble Stock Down 1.2%
PG opened at $150.67 on Thursday. The firm's 50-day simple moving average is $155.26 and its 200-day simple moving average is $159.72. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The firm has a market cap of $352.64 billion, a price-to-earnings ratio of 23.14, a PEG ratio of 4.05 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the firm earned $1.40 EPS. The firm's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 490 shares of the company's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider owned 12,616 shares of the company's stock, valued at approximately $1,920,533.68. This represents a 3.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the transaction, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 in the last quarter. 0.20% of the stock is owned by corporate insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report